Privo Technologies is a biotechnology company that develops therapeutics to eliminate cancers and prevent recurrence. Its products include PRV111, a nanoengineered polymeric patch with embedded cisplatin nanoparticles to treat tumor cancers; PRV131, an intratumoral injection system that allows for direct drug administration into the tumor site; and PRV211, a chemotherapy patch used during surgery for FDA regulations.